Nanotechnology Reviews,
Год журнала:
2024,
Номер
13(1)
Опубликована: Янв. 1, 2024
Abstract
The
limitations
of
traditional
drug
therapy
have
driven
the
creation
and
development
novel
cell
membrane-coated
nanoparticle
(CMNP)
platforms.
Since
introduction
CMNP
concept
method
in
2011,
an
increasing
number
studies
focusing
on
this
field
been
widely
conducted.
Despite
growing
body
literature,
comprehensive
bibliometric
analysis
is
still
lacking.
This
study
conducted
a
CMNP-related
publications
sourced
from
Web
Science
Core
Collection
database,
covering
period
January
1,
to
December
31,
2023.
included
co-authorships,
co-citations,
co-occurrences
countries,
institutions,
authors,
references,
keywords.
Visualized
tools
such
as
Citespace,
VOSviewer,
R
Package
Bibliometrix
were
employed
present
data.
A
total
780
included,
with
China
contributing
highest
(75.64%,
n
=
590).
annual
increased
consistently
2011
2023,
indicating
global
interest
field.
Prof.
Liangfang
Zhang
United
States
recognized
founder
leading
figure
area.
top
three
academic
journals
field,
based
publication
volume,
are
ACS
Nano
(32
publications,
IF
2022
17.1),
Applied
Materials
Interfaces
9.5),
Advanced
Functional
(31
19)
among
185
scholarly
journals.
Reference
keyword
revealed
that
erythrocytes
macrophage
membranes
significant
research
hotspots.
primary
diseases
targeted
by
cancer
pulmonary
inflammation.
In
addition,
CMNPs
frequently
studied
conjunction
photothermal
photodynamic
therapy.
Furthermore,
also
summarized
timelines
for
various
membrane
coating
methods
three-step
preparation
process
CMNP.
provides
valuable
insights
guide
future
highlighting
importance
clinical
application.
Research
nanomaterials,
particularly
those
related
inflammation,
expected
remain
focal
point.
there
need
further
other
potential
nanomaterials.
serves
resource
researchers
quickly
comprehensively
understand
current
hotspots
emerging
frontiers
Molecules,
Год журнала:
2024,
Номер
29(7), С. 1424 - 1424
Опубликована: Март 22, 2024
Tumors
have
a
huge
impact
on
human
life
and
are
now
the
main
cause
of
disease-related
deaths.
The
means
treatment
surgery
radiotherapy,
but
they
more
damaging
to
organism
poor
postoperative
prognosis.
Therefore,
we
urgently
need
safe
effective
drugs
treat
tumors.
In
recent
years,
Chinese
herbal
medicines
been
widely
used
in
tumor
therapy
as
complementary
alternative
therapies.
Medicinal
edible
herbs
popular
become
hot
topic
research,
which
not
only
excellent
pharmacological
effects
activities,
also
almost
no
side
effects.
typical
medicine
food
homology,
some
components
Paeoniae
Radix
Alba
(PRA,
called
Baishao
China)
shown
good
efficacy
safety
against
cancer.
Numerous
studies
that
its
active
ingredients
cancer
through
various
pathways
one
important
many
antitumor
compound
formulas.
this
paper,
reviewed
literature
intervention
tumors
mechanism
action
years
found
there
is
large
amount
effect
total
glucosides
paeony
(TGP)
paeoniflorin
(PF),
well
an
in-depth
discussion
constituents,
with
view
promote
clinical
development
application
field
management.
Intravitreal
injections
of
antivascular
endothelial
growth
factor
(VEGF)
agents
are
the
primary
method
for
treating
retinal
vein
occlusion
(RVO).
However,
complex
structure
eye
anatomy
presents
ocular
barriers
that
impede
drug
delivery.
Additionally,
these
drugs
only
manage
complications
associated
with
RVO
and
fail
to
address
underlying
cause
vessel
occlusions.
Here,
we
describe
a
utilizes
functionalized
magnetically
driven
nanorobots
overcome
treat
RVO.
These
developed
using
hybrid
biomembrane
combines
stem
cell
membranes
liposome-derived
membranes,
enveloping
perfluorohexane,
iron
oxide
nanoparticles,
l-arginine.
After
intravitreal
injection,
can
move
directionally
through
penetrate
vitreous
body
reach
retina,
by
an
external
magnetic
field.
Subsequently,
actively
target
inflammation
sites
at
occluded
vessels
due
presence
membranes.
In
rat
model
RVO,
enhanced
targeting
accumulation
in
ischemic
were
demonstrated
following
injections.
Furthermore,
application
ultrasound
triggers
release
l-arginine
site
occlusion,
stimulating
production
nitric
oxide,
which
promotes
vasodilation
restores
blood
flow,
thereby
achieving
excellent
therapeutic
efficacy
We
believe
methods
hold
significant
promise
overcoming
challenges
delivery
effectively
clinical
applications.
Frontiers in Immunology,
Год журнала:
2023,
Номер
14
Опубликована: Ноя. 23, 2023
Dental
pulp
stem
cells
(DPSCs)
have
received
a
lot
of
attention
as
regenerative
medicine
tool
with
strong
immunomodulatory
capabilities.
The
excessive
inflammatory
response
involves
variety
immune
cells,
cytokines,
and
has
considerable
impact
on
tissue
regeneration.
use
DPSCs
for
controlling
inflammation
the
purpose
treating
inflammation-related
diseases
autoimmune
disorders
such
supraspinal
nerve
inflammation,
pulmonary
airways,
systemic
lupus
erythematosus,
diabetes
mellitus
is
likely
to
be
safer
more
than
traditional
medicines.
mechanism
anti-inflammatory
effects
relatively
complex,
it
may
that
they
themselves
or
some
substances
secrete
regulate
through
immune-related
signaling
pathways.
Most
current
studies
are
still
at
laboratory
cellular
level
animal
model
level,
believed
efforts
researchers,
DPSCs/SHED
expected
transformed
into
excellent
drugs
clinical
treatment
related
diseases.
Abstract
Hepatic
ischemia‐reperfusion
injury
(HIRI)
is
a
prevalent
issue
during
liver
resection
and
transplantation,
with
currently
no
cure
or
FDA‐approved
therapy.
A
promising
drug,
Cyclosporin
(CsA),
ameliorates
HIRI
by
maintaining
mitochondrial
homeostasis
but
has
systemic
side
effects
due
to
its
low
bioavailability
high
dosage
requirements.
This
study
introduces
biomimetic
CsA
delivery
system
that
directly
targets
hepatic
lesions
using
mesenchymal
stem
cell
(MSC)
membrane‐camouflaged
liposomes.
These
hybrid
nanovesicles
(NVs),
leveraging
MSC‐derived
proteins,
demonstrate
efficient
inflammatory
chemotaxis,
transendothelial
migration,
drug‐loading
capacity.
In
mouse
model,
the
NVs
accumulated
at
sites
entered
hepatocytes,
significantly
reduced
damage
restore
function
only
one‐tenth
of
dose
typically
required.
Proteomic
analysis
verifies
protection
mechanism,
which
includes
reactive
oxygen
species
inhibition,
preservation
integrity,
cellular
apoptosis,
suggesting
potential
for
this
strategy
in
intervention.
Abstract
The
strong
anti‐inflammatory
effect
of
methylprednisolone
(MP)
is
a
necessary
treatment
for
various
severe
cases
including
acute
spinal
cord
injury
(SCI).
However,
concerns
have
been
raised
regarding
adverse
effects
from
MP,
which
also
severely
limits
its
clinical
application.
Natural
polyphenols,
due
to
their
rich
phenolic
hydroxyl
chemical
properties,
can
form
dynamic
structures
without
additional
modification,
achieving
targeted
enrichment
and
drug
release
at
the
disease
lesion,
making
them
highly
promising
carrier.
Considering
application
challenges
natural
polyphenolic
platform
employed
efficient
delivery
reducing
systemic
side
effects.
Both
in
vitro
SCI
models
demonstrated
polyphenols
multiple
advantages
as
carriers
delivering
MP:
(1)
Achieved
maximum
injured
site
2
h
post‐administration,
met
desires
early
diseases;
(2)
Traceless
MP;
(3)
Reducing
effects;
(4)
Endowed
system
with
new
antioxidative
an
aspect
that
needs
be
addressed
diseases
treatment.
This
study
highlighted
prospect
robust
based
on
successfully
overcome
barrier
MP
treatment,
providing
possibility
widespread
Advanced Healthcare Materials,
Год журнала:
2024,
Номер
13(22)
Опубликована: Май 23, 2024
Abstract
The
hybridization
of
liposome
with
stem
cell
membranes
is
an
emerging
technology
to
prepare
the
nanovehicle
capacity
disease‐responsive
targeting.
However,
long‐term
storage
this
hybrid
has
received
limited
attention
in
literature,
which
essential
for
its
potential
applicability
clinic.
Therefore,
preservation
activity
cell‐hybrid
using
freeze‐drying
investigated
present
study.
Mesenchymal
synthesized
and
feasibility
under
different
conditions
examined.
Results
reveal
that
pre‐freezing
at
−20
°C
Tris
buffer
solution
(pH
7.4)
containing
10%
trehalose
can
well
preserve
liposomal
structure
least
three
months.
Notably,
major
membrane
proteins
on
are
protected
formulation
CXCR4‐associated
targeting
maintained
both
vitro
vivo.
Consequently,
stored
months
demonstrates
a
comparable
tumor
inhibition
as
fresh‐prepared
one.
study
provides
first
insights
into
lyophilization,
may
make
important
step
forward
enhancing
stability
these
promising
biomimetic
ease
logistics
freeze‐storage
clinical
applications.
Biomedicines,
Год журнала:
2025,
Номер
13(5), С. 1068 - 1068
Опубликована: Апрель 28, 2025
Background:
Sjögren's
syndrome
(SS)
is
an
autoimmune
disorder
characterized
by
sicca
and/or
systemic
manifestations.
In
this
study,
non-obese
diabetic
(NOD)
mice
were
used
as
animal
model
for
studying
SS,
to
evaluate
the
optimal
administration
route
and
dose
range
of
dental
pulp
stem
cells
(DPSCs)
in
treatment
sialadenitis
caused
SS.
Methods:
Different
doses
DPSCs
transplanted
into
submandibular
glands
(SMGs)
14-week-old
NOD
through
two
different
methods:
injection
or
retrograde
perfusion
catheter
orifice
SMG.
At
21
weeks
age,
saliva
flow
rate
(SFR),
ectopic
lymphocytes,
CD4+
T-cell
infiltration
measured.
Tumor
necrosis
factor-alpha
(TNF-α)
interferon-gamma
(IFN-γ)
glandular
tissues
also
quantitatively
detected.
Results:
Compared
with
untreated
PBS-injected
controls,
different-dose
groups
methods
showed
increased
varying
degrees,
reduced
lymphocytes
T
SMG,
decreased
IFN-γ/TNF-α
levels.
Finally,
we
compared
these
routes
found
that
2
×
105
presents
good
therapeutic
effects.
Conclusions:
DPSC
a
simple
effective
method,
which
worthy
further
investigation
clinical
trials.
Pharmaceutics,
Год журнала:
2024,
Номер
16(11), С. 1454 - 1454
Опубликована: Ноя. 14, 2024
Background.
Lipid–polymer
hybrid
nanoparticles
(LPHNPs)
offer
a
promising
method
for
delivering
methylprednisolone
(MePD)
to
treat
lung
inflammation,
addressing
aggregation
issues
seen
with
polymer-only
formulations.
Objectives.
This
study
aimed
develop
LPHNPs
MePD
delivery,
assessing
their
physicochemical
properties,
drug
loading,
cytocompatibility,
and
release
profiles,
ultimately
enabling
inhalable
microparticle-based
powder.
Methods.
The
were
formulated
using
α,β-poly(N-2-hydroxyethyl)-DL-aspartamide-g-Rhodamine
B-g-poly(lactic
acid)
(PHEA-g-RhB-g-PLA)
phospholipids
DPPC,
DOTAP,
DSPE-PEG2000
in
45:30:25
weight
ratio.
Their
size,
redispersion
after
freeze-drying,
loading
(DL%),
controlled
evaluated.
Cytocompatibility
was
assessed
on
16-HBE
cell
lines,
measuring
anti-inflammatory
effects
via
IL-6
IL-8
levels.
Spray
drying
optimized
produce
microparticles
mannitol
(MAN),
leucine
(LEU),
N-acetylcysteine
(NAC).
Results.
had
size
of
186
nm
DL%
2.9%
MePD.
They
showed
good
significantly
reducing
yielded
fine
particle
fraction
(FPF)
62.3%
mass
median
aerodynamic
diameter
(MMAD)
3.9
µm.
Inclusion
LPHNPs@MePD
(0.25%
w/v)
resulted
FPF
MMAD
values
56.7%
4.4
In
conclusion,
this
described
the
production
novel
powders
as
carriers
MePD-loaded
nanostructures
favorable
aerosol
performance,
indicating
potential
an
effective
therapy
inflammation
corticosteroids,
especially
treating
chronic
diseases.